Cefotetan

FDA Approved: * August 9, 2007
Pharm Company: * ABRAXIS PHARM
Category: Antibiotics

Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe coverage. Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan. Contents 1 Adverse effects 2 Spectrum of bacterial susceptibility 3 References 4 External links A... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cefotetan 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution
NDC: 0143-9670
Labeler:
West-ward Pharmaceuticals Corp
Cefotetan 2 g/1 Intramuscular; Intravenous Injection, Powder, for Solution
NDC: 0143-9671
Labeler:
West-ward Pharmaceuticals Corp
Cefotetan 1 g/10ml Intramuscular; Intravenous Injection, Powder, for Solution
NDC: 63323-385
Labeler:
App Pharmaceuticals, LLC
Cefotetan 2 g/20ml Intramuscular; Intravenous Injection, Powder, for Solution
NDC: 63323-386
Labeler:
App Pharmaceuticals, LLC
Cefotetan 10 g/1 Intravenous Injection, Powder, for Solution
NDC: 63323-396
Labeler:
App Pharmaceuticals, LLC

Related Brands

Drugs with the same active ingredients